ChromaDex Expands Niagen® IV And Injection Offerings
10 Sep 2024 //
BUSINESSWIRE
ChromaDex To Launch IV And Injectable Niagen At Wellness Clinics
16 Jul 2024 //
BUSINESSWIRE
ChromaDex to Launch Niagen+, the First-Of-Its-Kind Pharma-Grade IV & Inj Niagen
13 Jun 2024 //
BUSINESSWIRE
ChromaDex Gets US Orphan, Rare Pediatric Status For NRC In AT
07 Jun 2024 //
BUSINESSWIRE
ChromaDex wins orphan designation for rare ataxia drug
07 Jun 2024 //
PHARMACEUTICAL TECHNOLOGY